What Happened?

An online nicotine pouch seller based in Texas has hired a Washington D.C. lobbying firm to make its case to federal officials. Blue Star Strategies registered Northern Scandinavia Inc., of Missouri City, Texas, as a new client in a federal lobbying registration filed Friday, Nov. 13, with the work taking effect Nov. 1. ​

According to a Legis1 review of the registration, the firm will “educate government officials about harm reduction and adult access to FDA-approved nicotine pouches,” with health, advertising and consumer safety as its issue areas. Blue Star CEO Karen Tramontano is the only lobbyist listed.

Why Does it Matter to Me?

The rules on which pouches can be sold are shifting fast. The U.S. Food and Drug Administration (FDA) authorized four on! pouches on Aug. 4 and 11 Zyn Ultra pouches on Aug. 21, bringing its total to 43 authorized pouch products. In May, the agency said it generally won’t prioritize enforcement against some unauthorized pouches and e-cigarettes whose marketing applications are accepted and pending.

Pouches also reach kids. They were the second most common tobacco product among middle and high school students in 2025, used by 1.7%, according to the FDA’s 2025 National Youth Tobacco Survey findings, though use held steady from 2024. The FDA has also urged pouch makers to use child-resistant packaging after poison centers saw rising exposures, about 72% of them in children under 5.

Both Sides, Now

Supporters say pouches give adults who smoke a less harmful option, the harm reduction case Northern Scandinavia’s filing makes. In authorizing the Zyn Ultra products, the FDA found they contain lower levels of most harmful constituents than other oral and smokeless tobacco products.

Critics say the FDA is opening the door too wide. Yolonda Richardson, president of the Campaign for Tobacco-Free Kids, called the May policy “a gift to Big Tobacco” in a May statement from the anti-tobacco group, saying it lets illegal products stay on the market. On July 14, her group, the American Academy of Pediatrics and other health groups and parents sued the FDA over the enforcement policy, arguing it violates federal law.

What Happens Next?

The lawsuit is pending in federal court in Maryland. Blue Star’s first quarterly lobbying report for the client, due in January, will show how much the firm is being paid.

---

AllCiv makes it easy to stay politically informed and involved.

---

Spot something wrong? Report an issue with this article